U

University of Texas Health Science Center at Tyler | Center for Clinical Research

Research site

(Unclaimed)

Location

11937 US Highway 271, Tyler, Texas, United States of America

Site insights

Top conditions

Top treatments

BI 1291583

AZLI

PTI-801

Apixaban

Lysophosphatidic

Avelumab

Entinostat

Cabozantinib-s-Malate

Exemestane

Nicotine

Data sourced from clinicaltrials.gov

Work at this site?

CTV for research professionals allows users to enhance their site’s profile, add contact information, and more.

Learn more and claim site

Active trials

3 of 22 total trials

A Study to Test How Well BI 1291583 is Tolerated by People With Cystic Fibrosis Bronchiectasis (Clairafly™)

This study is open to adults aged 18 years and older with cystic fibrosis bronchiectasis.The purpose of this study is to find out whether a medicine...

Active, not recruiting

Bronchiectasis

Cystic Fibrosis

Drug: BI 1291583

Drug: Placebo

Locations recently updated

Clairleafᵀᴹ: A Study to Test Long-term Treatment With BI 1291583 in People With Bronchiectasis Who Took Part in a Previous Study With This Medicine

This study is open to adults aged 18 years and older with bronchiectasis. People can join the study if they were previously enrolled in another study...

Enrolling

Bronchiectasis

Drug: BI 1291583

Drug: Placebo matching BI 1291583

Study to Evaluate the Safety, Phage Kinetics, and Efficacy of Inhaled AP-PA02 in Subjects With Non-Cystic Fibrosis Bronchiectasis and Chronic Pulmonary Pseudomonas Aeruginosa Infection (Tailwind)

A phase 2, multi-center, double-blind, randomized, placebo-controlled study to evaluate the safety, phage kinetics, and efficacy of inhaled AP-PA02 a...

Enrolling

Lung Infection

Non-cystic Fibrosis Bronchiectasis

Other: Placebo

Biological: AP-PA02